Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Current FDA concern The FDA says compounded AOD-9604 may carry immunogenicity risks for some routes and may have problems linked to peptide impurities and product characterization
Tan X, Chen R, Zhu S, Wang H, Yan D, Zhang X, et al
[13] Cell Growth and Angiogenesis Research has shown that BPC-157 increases blood vessel growth in all areas of the body
In 3T3-L1 adipocyte cultures, 5-Amino-1MQ treatment reduced adipocyte size by approximately 40%, decreased expression of lipogenic genes DGAT1 and DGAT2 (diacylglycerol acyltransferases responsible for triglyceride synthesis), and reduced total lipid accumulation
US$ 21.51
US$ 20.25
US$ 29.43
US$ 29.04
US$ 22.71
US$ 27.91
US$ 25.48
US$ 26.15
US$ 21.86
